Resveratrol treatment does not reduce arterial inflammation in males at risk of type 2 diabetes: a randomized crossover trial

E. Boswijk, M. de Ligt, M.F.J. Habets, A.M.A. Mingels, W.D.V. Lichtenbelt, F.M. Mottaghy, P. Schrauwen, J.E. Wildberger, J. Bucerius*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages9
JournalNuklearmedizin
DOIs
Publication statusE-pub ahead of print - 16 Dec 2021

Keywords

  • resveratrol
  • arterial inflammation
  • atherosclerosis
  • positron emission tomography (PET)
  • PLAQUE INFLAMMATION
  • E-DEFICIENT
  • SUPPLEMENTATION
  • METAANALYSIS
  • METABOLISM
  • MORPHOLOGY
  • INHIBITOR
  • EFFICACY
  • THERAPY
  • DISEASE

Cite this